Medical Supply Transparency and Delivery Act

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

D BaldwinSponsor

45 cosponsors · 43 D, 2 I

45 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

This bill provides for the procurement and distribution of equipment and supplies needed to combat COVID-19 (i.e., coronavirus disease 2019).

What it does: CRS summary · Introduced in Senate · May 6, 2020

Medical Supply Transparency and Delivery Act

This bill provides for the procurement and distribution of equipment and supplies needed to combat COVID-19 (i.e., coronavirus disease 2019).

The bill sets forth responsibilities for the National Response Coordination Center (NRCC) of the Federal Emergency Management Agency, including that the NRCC must (1) direct the national production and distribution of critical medical equipment and supplies; (2) communicate with states, local governments, and Native American tribes regarding the availability and delivery schedule of equipment and supplies; and (3) make specified information publicly available.

The Department of Defense may detail members of the armed forces on active duty or civilian employees to support the NRCC.

The President, using authorities provided under the Defense Production Act of 1950, must establish a fair and reasonable price for and procure needed equipment and supplies.

The Government Accountability Office must annually submit a report to Congress assessing the Strategic National Stockpile.

The Council of the Inspectors General on Integrity and Efficiency shall designate an inspector general to oversee this bill's implementation.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Medical Supply Transparency and Delivery Act

Latest action (May 6, 2020): Read twice and referred to the Committee on Homeland Security and Governmental Affairs.

Policy area: Government Operations and Politics · Origin: Senate · Introduced: May 6, 2020

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.